Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FABP4 | P15090 | 2/20 | 0.36 |
| ▸ | FABP3 | P05413 | 1/20 | 0.34 |
| ▸ | FABP5 | Q01469 | 1/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | APEX1 | P27695 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2869222 | 0.97 | FABP4 (0.38) | FABP4FABP3FABP5KDM4EPOLB | |
| Hydrochloric Acid SCHEMBL11010689 | 0.94 | FABP4 (0.36) | FABP4FABP3FABP5KDM4EPOLB | |
| Ammonia Solution, Strong SCHEMBL9809148 | 0.94 | FABP4 (0.36) | FABP4FABP3FABP5KDM4EPOLB | |
| SCHEMBL2862401 | 0.94 | FABP4 (0.37) | FABP4FABP3FABP5KDM4EPOLB | |
| SCHEMBL7121356 | 0.87 | FABP4 (0.37) | FABP4FABP3FABP5KDM4EPOLB | |
| SCHEMBL28147772 | 0.84 | FABP4 (0.36) | FABP4FABP3FABP5KDM4EPOLB | |
| SCHEMBL27843854 | 0.84 | FABP4 (0.32) | FABP4FABP3FABP5 | |
| SCHEMBL11783087 | 0.82 | FABP4 (0.32) | FABP4FABP3FABP5KDM4EPOLB | |
| SCHEMBL18183340 | 0.82 | ALDH1A1 (0.32) | FABP4KDM4E | |
| SCHEMBL27798197 | 0.80 | DAPK1 (0.32) | FABP4FABP3FABP5KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1377640-B1 | AZO COMPOUNDS AND PROCESS OF PRODUCING THE SAME AND NOVEL INTERMEDIATE COMPOUNDS USED IN THE PROCESS OF PRODUCING AZO COMPOUNDS | FUJIFILM CORP (JP) | 2017-05-17 | — | — | EP | disclosed |
| EP-2084237-B1 | OZONE STABLE INK-JET INKS | HEWLETT PACKARD DEVELOPMENT CO (US) | 2016-07-06 | — | — | EP | disclosed |
| US-8353586-B2 | Ink jet printer, ink jet recording method, and recorded matter | SEIKO EPSON CORPORATION (JP) | 2013-01-15 | — | — | US | disclosed |
| US-8353586-B2 | Ink jet printer, ink jet recording method, and recorded matter | SEIKO EPSON CORPORATION (JP) | 2013-01-15 | — | — | US | disclosed |
| EP-1377642-B1 | COLORING COMPOSITION FOR IMAGE FORMATION AND METHOD FOR IMPROVING OZONE RESISTANCE OF COLOR IMAGE | FUJIFILM CORP (JP) | 2013-01-09 | — | — | EP | disclosed |
| US-8293436-B2 | Oxime derivative, photopolymerizable composition, color filter, and process for producing the same | FUJIFILM CORPORATION (JP) | 2012-10-23 | — | — | US | disclosed |
| US-8293436-B2 | Oxime derivative, photopolymerizable composition, color filter, and process for producing the same | FUJIFILM CORPORATION (JP) | 2012-10-23 | — | — | US | disclosed |
| US-8216749-B2 | Curable composition, negative type color filter and method of producing the same | FUJIFILM CORPORATION (JP) | 2012-07-10 | — | — | US | disclosed |
| US-20120120147-A1 | Ink Jet Printer, Ink Jet Recording Method, and Recorded Matter | SEIKO EPSON CORPORATION (JP) | 2012-05-17 | — | — | US | disclosed |
| US-8128215-B2 | Ink jet printer, ink jet recording method, and recorded matter | SEIKO EPSON CORPORATION (JP) | 2012-03-06 | — | — | US | disclosed |
| US-20070181034-A1 | Dye sets for inkjet imaging and ink sets using the same | ETHICON ENDO-SURGERY, INC. | 2007-08-09 | — | — | US | disclosed |
| US-20070181034-A1 | Dye sets for inkjet imaging and ink sets using the same | ETHICON ENDO-SURGERY, INC. | 2007-08-09 | — | — | US | disclosed |
| US-20070176991-A1 | Ink composition and recording method using the same | FUJIFILM CORPORATION (JP) | 2007-08-02 | — | — | US | disclosed |
| US-20070176991-A1 | Ink composition and recording method using the same | FUJIFILM CORPORATION (JP) | 2007-08-02 | — | — | US | disclosed |
| US-20070173641-A1 | Azo compound and process of producing the same, and novel compound and process of producing azo compounds using the same | FUJI PHOTO FILM CO., LTD. | 2007-07-26 | — | — | US | disclosed |
| US-20070173641-A1 | Azo compound and process of producing the same, and novel compound and process of producing azo compounds using the same | FUJI PHOTO FILM CO., LTD. | 2007-07-26 | — | — | US | disclosed |
| US-20070146453-A1 | Ink composition | SEIKO EPSON CORPORATION (JP) | 2007-06-28 | — | — | US | disclosed |
| US-20070146453-A1 | Ink composition | SEIKO EPSON CORPORATION (JP) | 2007-06-28 | — | — | US | disclosed |
| US-7211132-B2 | Ink set | SEIKO EPSON CORPORATION (JP) | 2007-05-01 | — | — | US | disclosed |
| US-7211132-B2 | Ink set | SEIKO EPSON CORPORATION (JP) | 2007-05-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070173641-A1 | Azo compound and process of producing the same, and novel compound and process of producing azo compounds using the same | CYP4A11, CYP4F11, CYP4X1 | FABP4 3804/4885FABP3 4787/4885FABP5 2513/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.